Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metkinen Chemistry is a Finnish biotechnology company specializing in the development and manufacture of reagents for oligonucleotide synthesis. The company provides a comprehensive portfolio of high-quality phosphoramidites, solid supports, and modified nucleosides essential for the production of DNA and RNA-based therapeutics. Serving a global clientele in the pharmaceutical and research sectors, Metkinen Chemistry supports the development of antisense oligonucleotides, siRNA, and mRNA technologies. Their core expertise lies in complex organic synthesis and the production of specialized building blocks for nucleic acid chemistry. They offer both catalog products and custom synthesis services to meet specific research and manufacturing requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metkinen Chemistry.